Coverage Initiated on Biotech; Analyst Says, ‘Time to Buy’

Source: Streetwise Reports   03/14/2018 Sarah Weber, an analyst with Piper Jaffray & Co., made the case for investing in this biotherapeutic development firm. A March 9 research note indicated that Piper Jaffray & Co. launched [...]
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.